Novartis AG (NOVN.SW) — the peer cohort
As of 2026-11-21 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.
Novartis AG ranks 16 of 16 in its cohort on the Closelooknet composite (58/100) — the cohort is led by Halozyme Therapeutics Inc at 72/100.
| Name | Composite | Momentum | Quality | Valuation | Signal | Off 52w high |
|---|---|---|---|---|---|---|
| NOVN.SW Novartis AG | 58 | 74 | 82 | 39 | ok | 6.7% |
| HALO Halozyme Therapeutics Inc | 72 | 68 | 94 | 50 | info | 31.8% |
| ONC BeOne Medicines AG | 66 | 87 | 67 | 29 | ok | 8% |
| REGN Regeneron Pharmaceuticals Inc | 65 | 90 | 72 | 47 | neutral | 7.2% |
| UCB.BR UCB SA | 65 | 77 | 71 | 42 | info | 7.2% |
| ARGX.BR Argen-X | 64 | 80 | 73 | 25 | ok | 7.8% |
| LLY Eli Lilly and Company | 64 | 88 | 90 | 22 | bear | 8.7% |
| ANN.AU Ansell Ltd | 63 | 96 | 47 | 49 | ok | 2.7% |
| ARGX argenx NV ADR | 63 | 71 | 73 | 25 | ok | 13.7% |
| ROVI.MC Laboratorios Farmaceuticos ROVI | 63 | 59 | 74 | 43 | info | 26% |
| ORNAV.HE Orion Oyj A | 63 | 95 | 84 | 27 | ok | 3.5% |
| ORNBV.HE Orion Oyj B | 63 | 95 | 84 | 27 | ok | 3.5% |
| RIGL Rigel Pharmaceuticals Inc | 63 | 73 | 89 | 77 | info | 23.8% |
| SAN.PA Sanofi SA | 63 | 77 | 69 | 59 | bull | 4.6% |
| DXCM DexCom Inc | 62 | 69 | 78 | 33 | watch | 14.3% |
| HQY HealthEquity Inc | 62 | 68 | 70 | 40 | info | 14.1% |
Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.
FAQ · from the current data · as of 2026-11-21
Quick answers
Who are Novartis AG's peers in the Closelooknet universe?
The cohort is drawn from shared Closelooknet index membership first, then sector: Halozyme Therapeutics Inc (HALO), BeOne Medicines AG (ONC), Regeneron Pharmaceuticals Inc (REGN), UCB SA (UCB.BR), Argen-X (ARGX.BR), Eli Lilly and Company (LLY), Ansell Ltd (ANN.AU), argenx NV ADR (ARGX) and others, as of 2026-11-21.
How does NOVN.SW score against its peers?
Novartis AG's composite reads 58/100, ranking 16 of 16 in its cohort as of 2026-11-21; the cohort's highest composite is Halozyme Therapeutics Inc at 72/100. Closelooknet scores are research diary readings, not ratings or advice.
Related in the Closelooknet universe
- HALO Halozyme Therapeutics Incsector
- ONC BeOne Medicines AGsector
- REGN Regeneron Pharmaceuticals Incsector
- UCB.BR UCB SAsector
- ARGX.BR Argen-Xsector
- LLY Eli Lilly and Companysector
- ANN.AU Ansell Ltdsector
- ARGX argenx NV ADRsector
- ROVI.MC Laboratorios Farmaceuticos ROVIsector
- ORNAV.HE Orion Oyj Asector
- ORNBV.HE Orion Oyj Bsector
- RIGL Rigel Pharmaceuticals Incsector
- SAN.PA Sanofi SAsector
- DXCM DexCom Incsector
- HQY HealthEquity Incsector
- MEDP Medpace Holdings Incsector
- PTGX Protagonist Therapeutics Incsector
- CEVI.ST CellaVision ABsector
- FPH.AU Fisher & Paykel Healthcare Corporation Ltdsector
- GMED Globus Medicalsector